Japan OK’s Pfizer Vaccine for XBB.1.5 Omicron Variant
15:05 JST, September 2, 2023
The Health, Labor and Welfare Ministry gave special approval for the manufacture and sale of Pfizer Inc.’s vaccine for XBB.1.5, a new omicron variant of the novel coronavirus, in Japan on Friday.
Those 6 months or older will be eligible to receive the U.S. pharmaceutical company’s vaccine. Inoculations will begin on Sept. 20 in preparation for the expected spread of coronavirus infections during the year-end and New Year’s holidays.
The shots will be administered for free during fiscal 2023.
"Society" POPULAR ARTICLE
-
Japan Court OKs Sex Change without Surgery
-
3 Climbers Die On Mt. Fuji Within 2 Days Of Opening; Japan Police, Guides Urge Climbers To Prepare Well, Make Wise Decisions
-
Sex Crime Perpetrators Linked to U.S. Military in 166 Cases in Japan over 35 years; Local, Prefectural Governments Often Not Aware of Crimes
-
New Mt. Fuji Rules Reduce ‘Bullet Climbers’ by 90%; Access to Japan’s Iconic Peak Limited from Yamanashi Pref. Side
-
Tokaido Shinkansen Trains Suspended Between Hamamatsu and Nagoya Due to Accident; Resuming Services Expected Noon at Earliest
JN ACCESS RANKING
- Aviation Fuel Shortage Causes Problems at Regional Airports; Growing Demand, Lack of Workers to Transport
- Prices of over 10,000 Food and Beverage Items to Rise This Year; Figure is down from over 30,000 Last Year
- Sony Group to End Production of Blu-ray Discs; Market Has Shrunk Due To Growth Of Hard Disk Drives, Streaming
- Japan Ministry Concerned Over Same-Sex Couple Receiving City-Issued Resident Certificates Referring to ‘Common-Law Husband’
- Japan Court OKs Sex Change without Surgery